Cargando…
Correction to: The clinical usage of liposomal amphotericin B in patients receiving renal replacement therapy in Japan: a nationwide observational study
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Singapore
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925451/ https://www.ncbi.nlm.nih.gov/pubmed/33417077 http://dx.doi.org/10.1007/s10157-020-02004-5 |
| _version_ | 1783659270332481536 |
|---|---|
| author | Obata, Yoko Takazono, Takahiro Tashiro, Masato Ota, Yuki Wakamura, Tomotaro Takahashi, Akinori Sato, Kumiko Miyazaki, Taiga Nishino, Tomoya Izumikawa, Koichi |
| author_facet | Obata, Yoko Takazono, Takahiro Tashiro, Masato Ota, Yuki Wakamura, Tomotaro Takahashi, Akinori Sato, Kumiko Miyazaki, Taiga Nishino, Tomoya Izumikawa, Koichi |
| author_sort | Obata, Yoko |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7925451 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer Singapore |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79254512021-03-19 Correction to: The clinical usage of liposomal amphotericin B in patients receiving renal replacement therapy in Japan: a nationwide observational study Obata, Yoko Takazono, Takahiro Tashiro, Masato Ota, Yuki Wakamura, Tomotaro Takahashi, Akinori Sato, Kumiko Miyazaki, Taiga Nishino, Tomoya Izumikawa, Koichi Clin Exp Nephrol Correction Springer Singapore 2021-01-08 2021 /pmc/articles/PMC7925451/ /pubmed/33417077 http://dx.doi.org/10.1007/s10157-020-02004-5 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Correction Obata, Yoko Takazono, Takahiro Tashiro, Masato Ota, Yuki Wakamura, Tomotaro Takahashi, Akinori Sato, Kumiko Miyazaki, Taiga Nishino, Tomoya Izumikawa, Koichi Correction to: The clinical usage of liposomal amphotericin B in patients receiving renal replacement therapy in Japan: a nationwide observational study |
| title | Correction to: The clinical usage of liposomal amphotericin B in patients receiving renal replacement therapy in Japan: a nationwide observational study |
| title_full | Correction to: The clinical usage of liposomal amphotericin B in patients receiving renal replacement therapy in Japan: a nationwide observational study |
| title_fullStr | Correction to: The clinical usage of liposomal amphotericin B in patients receiving renal replacement therapy in Japan: a nationwide observational study |
| title_full_unstemmed | Correction to: The clinical usage of liposomal amphotericin B in patients receiving renal replacement therapy in Japan: a nationwide observational study |
| title_short | Correction to: The clinical usage of liposomal amphotericin B in patients receiving renal replacement therapy in Japan: a nationwide observational study |
| title_sort | correction to: the clinical usage of liposomal amphotericin b in patients receiving renal replacement therapy in japan: a nationwide observational study |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925451/ https://www.ncbi.nlm.nih.gov/pubmed/33417077 http://dx.doi.org/10.1007/s10157-020-02004-5 |
| work_keys_str_mv | AT obatayoko correctiontotheclinicalusageofliposomalamphotericinbinpatientsreceivingrenalreplacementtherapyinjapananationwideobservationalstudy AT takazonotakahiro correctiontotheclinicalusageofliposomalamphotericinbinpatientsreceivingrenalreplacementtherapyinjapananationwideobservationalstudy AT tashiromasato correctiontotheclinicalusageofliposomalamphotericinbinpatientsreceivingrenalreplacementtherapyinjapananationwideobservationalstudy AT otayuki correctiontotheclinicalusageofliposomalamphotericinbinpatientsreceivingrenalreplacementtherapyinjapananationwideobservationalstudy AT wakamuratomotaro correctiontotheclinicalusageofliposomalamphotericinbinpatientsreceivingrenalreplacementtherapyinjapananationwideobservationalstudy AT takahashiakinori correctiontotheclinicalusageofliposomalamphotericinbinpatientsreceivingrenalreplacementtherapyinjapananationwideobservationalstudy AT satokumiko correctiontotheclinicalusageofliposomalamphotericinbinpatientsreceivingrenalreplacementtherapyinjapananationwideobservationalstudy AT miyazakitaiga correctiontotheclinicalusageofliposomalamphotericinbinpatientsreceivingrenalreplacementtherapyinjapananationwideobservationalstudy AT nishinotomoya correctiontotheclinicalusageofliposomalamphotericinbinpatientsreceivingrenalreplacementtherapyinjapananationwideobservationalstudy AT izumikawakoichi correctiontotheclinicalusageofliposomalamphotericinbinpatientsreceivingrenalreplacementtherapyinjapananationwideobservationalstudy |